Abstract: A synthetic method for the preparation of the anti-tumor drug Etoposide. In one embodiment, the method includes the direct condensation of 4′-demethyl-epipodophylloxin with 2,3-di-O-dichloroacetyl-(4,6-O-ethylidene)-&bgr;-D-glucopyranose in the presence of trimethylsilyl trifluoromethane sulfonate (TMSOTf) to yield 4′-demethylepipodophyllotoxin-4-(2,3-di-O-dichloroacetyl-4,6-O-ethylidene)-&bgr;-D-glucopyranoside, followed by conversion of the same to etoposide. Other methods include use of different Lewis acids as catalyst, as well as different substituted glucopyranosides. This method provides enhanced yields over existing synthetic techniques, reduced reaction times and permits more favorable isolation reaction procedures.

Abstract: The present invention relates to a process for the preparation of a carboxylic acid by carbonylating the corresponding alcohol in carbon monoxide atmosphere and in the presence of water, a solvent, a palladium catalyst and a promoter system consisting of an organic or inorganic halide and an organic sulphonic acid, at a temperature in the range of 50-250° C., at a pressure in the range of 50-2000 psig for 1 to 10 hours, the concentration of the catalyst being one mole of catalyst per every 50-50000 moles of the alcohol, the amount of the organic or inorganic halide being in the range of 5-500 moles per mole of the catalyst, and the amount of the organic sulphonic acid being in the range of 5-500 moles per mole of the catalyst, collecting the resulting product.

Abstract: Kits and methods for measuring enzyme activities and metabolites using NAD analogs and NADP analogs are disclosed. The analogs can be used as replacements for NAD and NADP cofactors in analytical procedures. Preferred aspects of the invention include kits containing the NAD analogs and NADP analogs for use in the measurement of ethanol, lactic acid, 3-hydroxybutyric acid, glucose, glycerol, triglycerides, alpha-glycerophosphate, bile acids, creatine kinase activity, glucose-6-phosphate dehydrogenase activity and lactic acid dehydrogenase activity in analytical samples.

Abstract: This invention relates to pharmaceutical composition comprising a lipophilic oligosaccharide antibiotic in a substantially monomeric form.

Abstract: A preparative method of separating oligosaccharides from contaminants such as peptides and salts, comprising the steps of reacting a solution containing oligosaccharides and contaminants with a solid support comprising graphitized carbon such that the oligosaccharides substantially bind to the solid support; washing the support to remove any contaminants not bound to the solid support; and eluting the bound oligosaccharide from the support without eluting bound contaminants to obtain a solution of oligosaccharides substantially free of contaminants.

Abstract: The present invention relates to a crystalline polymorph of 2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxy-phenyl)-1-methylethyl]amino]ethyl]phenoxy]acetic acid having strong diffraction peaks (diffraction angle: 2&thgr;±0.1°) at 10.8, 19.1, 19.3, 19.8, 20.6 and 27.0° in powder X-ray diffraction pattern, which has potent &bgr;2- and &bgr;3-adrenoceptor stimulating effects and is useful as an agent for relieving pain and promoting the removal of calculi in urolithiasis, and the like. For example, the crystalline polymorph can be prepared by hydrolyzing ethyl 2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]-amino]ethyl]phenoxy]acetate phosphate by sodium hydroxide, adding an aqueous phosphoric acid solution at 40° C. and over, adding a mixed solvent of water and methanol or methanol to the resulting compound, and stirring the suspension at 40° C. to reflux temperature for 30 minutes to several hours.

Abstract: The subject invention relates to a process for the crystallization of di-carboxylic acids comprising dissolving the crude dicarboxylic acid at a temperature sufficient to dissolve the crude diacid in the solvent, whereby portion of the said solvent evaporates, increasing the concentration of the dicarboxylic acid in the said solution, transferring the said solution from the evaporator to a crystallizer, comprising a solid cylindrical impeller conforming to the shape of the crystallizer related by means of a cylindrical shaft attached to the spped motor, adding the additives selected from surfactants, buffer salts and/or acid salts or mixture thereof in the said evaporated solution in the said crystallizer, cooling the said mixture resulting in the formation of crystals of dicarboxylic acids, wherein the said crystallization takes place in the annular space between the impeller and the crystallizer wall.

Abstract: The storage of alkylaminoalkyl (meth)acrylate is made in a container made of stainless steel whose wall surface has not more than 1.6 &mgr;m for the Ra defined in JIS B 0601. And the compound is stored in a container having a water concentration of not more than 0.1 vol. % and a molecular oxygen concentration exceeding 0 to 10 vol. % in the gas phase part of the container. When the compound is handled under these conditions, it is enabled to retain the (meth)acrylic acid concentration therein below 0.1 wt. %, prevented from producing a polymer or a precipitate, and precluded from coloration.

Abstract: Disclosed herein is a novel 1-alkenyl ether compound which can be cured by radical polymerization.

Abstract: Esters and other carboxylic acid derivatives of 3,3,4,4-tetrahydroperfluoroalkylcarboxylic acids are made by the iron promoted reaction of an ester of bromodifluoroacetic acid or other carboxylic acid derivatives and a (perfluoroalkyl)ethylene. The resulting products may be converted to the corresponding alkali metal or ammonium carboxylate slits which are useful as surfactants in fluoroolefin polymerizations.

Abstract: The present invention concerns new phospholipid derivatives of nucleosides of the general formula (I) in which R1 represents a straight-chained or branched, saturated or unsaturated aliphatic residue with 9-14 carbon atoms which can optionally be substituted once or several times; R2 can represent a straight-chained or branched, saturated or unsaturated aliphatic residue with 8-12 carbon atoms which can optionally be substituted once or several times; m is 2 or 3; A can represent a methylene group or an oxygen; Nuc can be a nucleoside or a residue derived from a nucleoside derivative; and tautomers thereof and their physiologically tolerated salts of inorganic and organic acids and bases as well as pharmaceutical preparations containing these compounds.

Abstract: An industrially advantageous method of producing &bgr;-halogeno-&agr;-aminocarboxylic acids is provided. Methods are also provided of producing optically active N-protected-S-phenylcysteines having high optical purity and of intermediates thereof, respectively, in which the above production method is utilized. A method of producing &bgr;-halogeno-&agr;-aminocarboxylic acids or salts thereof is disclosed which comprises halogenating the hydroxyl group of a &bgr;-hydroxy-&agr;-aminocarboxylic acid (in which the basicity of the amino group in &agr;-position is not masked by the presence of a substituent on said amino group) or a salt thereof with an acid with a halogenating agent.

Abstract: The invention discloses pentenoic acid hydroxycarbonylation into adipic acid. More particularly, it concerns one pentenoic acid hydroxycarbonylation method involving reaction water and carbon monoxide, in the presence of a catalyst comprising at least rhodium and/or iridium and an iodinated or brominated catalytic promoter. In the method, the catalyst is derived at least in part from a previous pentenoic acid hydroxycarbonylation operation. The reaction is effected in the presence of an amount of branched carboxylic diacids having 6 carbon atoms not exceeding 200 grams per kilogram reaction mixture.

Abstract: Compounds of formula I wherein A is a group OCHR4 or N═CR4; Y is O or NH, R1 is C1-C6-alkyl; R2 is C1-C6-alkyl or C1-C6-alkyl substituted by 1 to 5 fluorine atoms; R3 is C1-C6-alkyl, C1-C6-alkoxy, C3-C6-cycloalkyl, C3-C6-cycloalkoxy, C2-C6-alkenyl, C2-C6-alkenyloxy, C2-C6-alkinyl, C2-C6-alkinyloxy, C1-C6-alkoxycarbonyl, CN or halogen, aryl, hetaryl, heterocyclyl, aryloxy, hetaryloxy or heterocyclyloxy, whereby the above-mentioned groups, with the exception of CN and halogen, may be substituted by the same or different substituents; R4 is methyl, ethyl or cyclopropyl; R6 is hydrogen or methyl; have microbicidal, insecticidal and acaricidal activity, and may be used to control plant-pathogenic fungi, acarids and insects in agriculture and in the field of hygiene.

Abstract: The present invention relates to novel amidino compound of formula (I). to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use as selective inhibitors of inducible nitric oxide synthase.

Abstract: The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble &bgr;-glucan composition comprising &bgr;-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).

Abstract: The invention concerns a hydroxypropyl starch ester (HPS ester), compositions containing it, and a process for the preparation thereof. According to the invention, the molar substitution in the HPS ester is 2 at the most and the substitution degree in the ester group is at least 1. The HPS ester is prepared by hydroxypropylating a starch-containing base material in an aqueous alkanol medium. A starch component can be prepared of the HPS ester containing 90 to 60% by weight HPS ester and 10 to 40% by weight of a plasticizer. Compositions which are suited for, e.g., coating board or paper and for use as a component in labelling adhesives or paint, can be made from the starch component by combining it with auxiliaries known as such within the polymer and plastics technology.

Abstract: Disclosed are a method of dispersing a pigment, a pigment dispersion, a coating composition comprising said pigment dispersion, an method of making a coating composition, and a method of improving the appearance of a coating composition. The pigment dispersion of the invention requires at least one pigment subjected to an action to decrease the average particle size of the pigment in the presence of an amine functional cellulose ester resin.

Abstract: The present invention pertains to novel inhibitors of DNA glycosylases. The invention is based at least in part on the observation that specific substituted pyrrolidines, and analogs thereof, are capable of specifically inhibiting DNA glycosylases, e.g., as transition state analogs, and consequently are useful for modulation of DNA repair. Such compounds can, for example, be used for treating subjects having a disorder associated with excessive cell proliferation, such as in the treatment of various cancers. Furthermore, these glycosylase inhibitors can be used as anti-bacterial, anti-viral and anti-fungal agents.

Abstract: The present invention is, generally, directed to the use of betulinic acid and derivatives thereof for the treatment of neuroectodermal tumors. The present invention is based on the discovery that betulinic acid and its derivatives are potent anti-neuroectodermal agents. As disclosed herein, betulinic acid and its derivatives are useful for the treatment of neuroectodermal tumors, including, due to its distinct mechanism of action, neuroectodermal tumors that are resistant to conventional chemotherapeutical agents. In addition to the new use of known compounds, the invention discloses novel compounds and pharmaceutical compositions for the treatment of neuroectodermal tumors.